Nexalin Technology, Inc. (NXL)
$0.32-3.03%Close
SELLCRISIS · day 21
Key stats
Short interest · FINRA settlement 2026-07-31
- Market cap
- $7M
- Avg volume
- 476.4K
- Beta
- 4.04
- P/E (TTM)
- -0.66
- Short % float
- 1.82%
- Days to cover
- 1.5
- SI change
- -50.6%
- 1W
- -5.88%
- 1M
- -33.33%
- 3M
- -15.79%
- YTD
- -44.83%
- vs SPY 1W
- -4.69%
- vs SPY 1M
- -36.65%
- vs SPY 3M
- -18.18%
- vs SPY YTD
- -56.58%
Sector peers
Same-sector names ranked by LOPJLB quality proximity · Healthcare
- AVRBUYAnteris Technologies Global Corp.RECOVERYQ 31$8.80-2.00%
- NOTVSELLInotiv, Inc.CRISISQ -1$0.01+0.00%
- CATXBUYPerspective Therapeutics, Inc.RECOVERYQ 7$3.19-3.33%
- CLPTBUYClearPoint Neuro, Inc.RECOVERYQ 7$15.17-1.43%
- GELSSELLGelteq Limited Ordinary SharesCRISISQ -13$0.53-5.36%
- ACONBUYAclarion, Inc.RECOVERYQ -29$2.66-1.85%
- XNCRBUYXencor, Inc.BULLQ 17$29.00+4.32%
- RLAYBUYRelay Therapeutics, Inc.BULLQ 4$19.76+1.65%
- LEXXBUYLexaria Bioscience Corp.RECOVERYQ -8$10.54-3.48%
- ALTBUYAltimmune, Inc.RECOVERYQ -5$3.11+0.00%
- BMGLSELLBasel Medical Group Ltd Ordinary SharesCRISISQ -20$4.80-9.43%
- SLNBUYSilence Therapeutics plcRECOVERYQ 3$13.29+0.15%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 0
- VALUE
- 3
- GROWTH
- 0
- GARP
- 0
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-166.9%
REV YoY-
ROE-278.2%
EPS YoY-
ROA-299.2%
GROSS-148
OP-4203
NET-4139
[VALUATION]
P/E TTM-0.66
P/E FWD-
SECTOR PE22.66
INDUSTRY PE24.61
P/B4.39
P/FCF-
EV/EBITDA-0.66
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E-
ALTMAN Z-
CURR RATIO1.25
ND/EBITDA-
BETA4.04
